Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication

Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up

(2012) Giuseppe Cianchini et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

(2012) Yael A. Leshem et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Immunoadsorption in Dermatology

(2012) Damian Meyersburg et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Recommandations des centres de référence des maladies bulleuses auto-immunes pour le diagnostic et la prise en charge du pemphigus

(2011) P. Joly et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Rituximab for Patients With Refractory Mucous Membrane Pemphigoid

(2011) Christelle Le Roux-Villet   ARCHIVES OF DERMATOLOGY

Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients

(2011) J.H. Kim et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients

(2011) M. Kasperkiewicz et al.   BRITISH JOURNAL OF DERMATOLOGY

Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

(2011) M. Behzad et al.   BRITISH JOURNAL OF DERMATOLOGY

Low-dose rituximab is effective in pemphigus

(2011) B. Horváth et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of subepidermal immunobullous diseases

(2011) Donna A. Culton et al.   CLINICS IN DERMATOLOGY

Therapieresistentes Anti-Laminin-332-Schleimhautpemphigoid

(2011) A. Recke et al.   HAUTARZT

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

(2011) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Intravenous Immunoglobulin Therapy in Autoimmune Mucocutaneous Blistering Diseases

(2010) Hakan M. Gürcan et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Immunoadsorption in dermatology

(2010) Enno Schmidt et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients

(2010) S. Lourari et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab

(2008) Martin Pfütze et al.   DERMATOLOGY

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

(2008) Michael Hertl et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Rituximab Immunotherapy in Pemphigus: Therapeutic Effects Beyond B-Cell Depletion

(2008) Giovanna Zambruno et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Rituximab Exerts a Dual Effect in Pemphigus Vulgaris

(2008) Rüdiger Eming et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY